ARRDC3 and neoplasm: Assessing the tumour-free survival of the other genotypes, we observed a slight but non-significant decrease in tumour latency in Eμ-MycT/+;Arrdc3+/− animals (median survival = 77 days) compared to the Eμ-MycT/+;Arrdc3+/+ control mice (median survival = 91 days) (Mantel-Cox test, df = 1, X2 = 2.981, p > 0.05 (p = 0.0842)) (Fig. 4B).